000 03850nam a2200337 i 4500
999 _c399366
_d399366
001 399366
003 ES-MaUEC
005 20240415173839.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 231024s2023 si | fo |||| 0|eng d
020 _a9789819965649
024 7 _a10.1007/978-981-99-6564-9
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRS199.5
_b2023 EB
245 0 0 _aAdvanced Drug Delivery :
_bMethods and Applications
_cedited by Tuhin Subhra Santra, Ashwini Uma Surendra Shinde
250 _a1st ed. 2023
264 1 _aSingapore
_bSpringer Nature Singapore
_c2023
300 _a1 recurso en línea
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 0 _aStudies in Mechanobiology, Tissue Engineering and Biomaterials
_x1868-2014
_v26
505 0 _aChapter 1. Biological methods -- Chapter 2. Liposomal based drug delivery system -- Chapter 3. Hydrogel-based drug delivery strategies -- Chapter 4. Monoclonal antibodies -- Chapter 5. Electroporation -- Chapter 6. Photoporation -- Chapter 7. Mechanoporation -- Chapter 8. Magnetoporation -- Chapter 9. Microinjection -- Chapter 10. Jet injection -- Chapter 11. Sonoporation -- Chapter 12. Device based drug delivery techniques - microfluidics Chapter 13. Nanoparticles drug delivery systems -- Chapter 14. BioMaterials -- Chapter 15. Implanted drug delivery systems -- Chapter 16. Transdermal drug delivery systems -- Chapter 17. Subcutaneous drug delivery systems -- Chapter 18. Nasopulmonary drug delivery systems -- Chapter 19. Mucosal drug delivery systems -- Chapter 20. Intrauterine drug delivery systems -- Chapter 21. Gastro retentive drug delivery systems -- Chapter 22. Endoscopic assisted drug delivery -- Chapter 23. Theranostics.
520 _aThis book provides an overview of various drug delivery systems at the cellular level including biological, chemical methods, and most importantly physical methods such as photoporation, electroporation, mechanoporation, and device-based techniques (e.g., microfluidics), as well as organism-level techniques including nanomaterials, biomaterials, and transdermal. Drug delivery (DD) can be defined as the method and route by which an active pharmaceutical ingredient (API) is administered to promote its desired pharmacological effect and/or convenience and/or to reduce adverse effects. Drug delivery systems are developed to maximize drug efficacy and minimize side effects. As drug delivery technologies improve, the drug becomes safer and more comfortable for patients to use. During the last seven decades, extraordinary progress has been made in drug delivery technologies, such as systems for long-term delivery for months and years, localized delivery, and targeted delivery. The advances, however, will face the next phase considering the future technologies that we need to overcome many physicochemical barriers for new formulation development and biological unknowns for treating various diseases. Thus, various technologies are built at a single-cell level as well as an organism level. This book is useful at the university level for graduate courses or research studies and biotechnology-based companies with research and development on cell-based analysis, diagnosis, or drug screening. This book is also very useful for researchers in drug delivery technologies, which came in frontier research for the past decade.
988 _aSpringer_BiomedLife_2023
650 7 _2embne
_9667667
_aSistemas de liberación de fármacos
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-99-6564-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b04/2024
_dz
_eb
_zSI